Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (231-240 of 567) with videos related to

Pageof 57
Sort By:
Journal of the American College of Cardiology|January 1, 1988
Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery diseaseR M Califf, D B Mark, F E Harrell, et al.
European Heart Journal|August 1, 1995
Progress culminating from ten years of clinical trials on thrombolysis for acute myocardial infarction. GUSTO-I Steering Committee. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesF Van de Werf, R M Califf, P W Armstrong, et al.
European Heart Journal|March 20, 2003
Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission?A Hersi, Y Fu, B Wong, et al.
Circulation|May 16, 2000
Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trialR M Califf, K S Pieper, K L Lee, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1992
Exploration of rapid bedside monitoring of coagulation and fibrinolysis parameters during thrombolytic therapyD C Sane, N J Gresalfi, L A Enney-O'Mara, et al.
Journal of the American College of Cardiology|May 12, 2000
Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb Angioplasty Substudy. Global Use of Strategies to Open Occluded Arteries in Acute Coronary SyndromesD Hasdai, C B Granger, S S Srivatsa, et al.
Annals of Internal Medicine|January 15, 1993
Value of the history and physical in identifying patients at increased risk for coronary artery diseaseD B Pryor, L Shaw, C B McCants, et al.
The New England Journal of Medicine|February 22, 1996
Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) InvestigatorsE B Sgarbossa, S L Pinski, A Barbagelata, et al.
The American Journal of Cardiology|March 15, 1996
Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapyK W Mahaffey, C B Granger, R Collins, et al.
Journal of the American College of Cardiology|March 15, 2000
Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessmentA Shah, G S Wagner, C B Granger, et al.
Pageof 57

Showing results (231-240 of 567) with videos related to

Sort By:
Pageof 57
Journal of the American College of Cardiology|January 1, 1988
Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery diseaseR M Califf, D B Mark, F E Harrell, et al.
European Heart Journal|August 1, 1995
Progress culminating from ten years of clinical trials on thrombolysis for acute myocardial infarction. GUSTO-I Steering Committee. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesF Van de Werf, R M Califf, P W Armstrong, et al.
European Heart Journal|March 20, 2003
Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission?A Hersi, Y Fu, B Wong, et al.
Circulation|May 16, 2000
Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trialR M Califf, K S Pieper, K L Lee, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1992
Exploration of rapid bedside monitoring of coagulation and fibrinolysis parameters during thrombolytic therapyD C Sane, N J Gresalfi, L A Enney-O'Mara, et al.
Journal of the American College of Cardiology|May 12, 2000
Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb Angioplasty Substudy. Global Use of Strategies to Open Occluded Arteries in Acute Coronary SyndromesD Hasdai, C B Granger, S S Srivatsa, et al.
Annals of Internal Medicine|January 15, 1993
Value of the history and physical in identifying patients at increased risk for coronary artery diseaseD B Pryor, L Shaw, C B McCants, et al.
The New England Journal of Medicine|February 22, 1996
Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) InvestigatorsE B Sgarbossa, S L Pinski, A Barbagelata, et al.
The American Journal of Cardiology|March 15, 1996
Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapyK W Mahaffey, C B Granger, R Collins, et al.
Journal of the American College of Cardiology|March 15, 2000
Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessmentA Shah, G S Wagner, C B Granger, et al.
Pageof 57